Status: current, Defined. Date: 31-Jan 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4664131000168112 | tozinameran injection, 195 x 1.3 mL vials (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4664141000168115 | tozinameran injection, 195 x 1.3 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4664191000168111 | BNT162b2 mRNA encoding SARS-CoV-2 spike protein injection, 195 x 1.3 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4664201000168114 | COVID-19 BNT162b2 mRNA child vaccine injection, 195 x 1.3 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4665381000168114 | BNT162b2 mRNA (messenger ribonucleic acid) encoding SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) spike glycoprotein injection, 195 x 1.3 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tozinameran injection, 195 x 1.3 mL vials | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| tozinameran injection, 195 x 1.3 mL vials | has MPUU | tozinameran injection, 1.3 mL vial | true | Inferred relationship | Some | 241553456 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Comirnaty Orange Cap 5 to less than 12 Years Dilute to Use Multidose injection, 195 x 1.3 mL vials | Is a | True | tozinameran injection, 195 x 1.3 mL vials | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product pack reference set
FHIR